Lysol's "SleepySol Bio" Named "Best Global Watch App" on Google Play

LEESOL announced that its sleep and mental health management app 'Sleepisol Bio' was selected as the Best App in the Global Watch category (Best for Watches) at the Google Play Best of 2025 awards ceremony announced on the 19th.

Google Play annually recognizes apps and games that have led technological and service innovation throughout the year, by country and category. This year's awards are seen as a testament to the rapid expansion of wearable-based personalized healthcare services in the global market.

Sleepisol Bio is an app that provides a personalized sleep management solution based on an individual's circadian rhythm. Beyond simple sleep induction, it features advanced AI analysis technology. Following its 2025 CES Innovation Award win, the app has also been recognized for its innovation on global platforms, achieving 1.2 million cumulative downloads and 100,000 monthly active users (MAU) in just 10 months.

This service uses AI to analyze biometric data, such as heart rate variability (HRV), collected from major wearable devices like the Samsung Galaxy Watch and Apple Watch, in real-time to provide personalized therapy tailored to optimal sleep, focus, stress, and healing. Therapies are segmented into areas such as improving sleep quality, enhancing work focus, and managing stress, enhancing the user's personalized mental health management experience.

Lysol is researching generative AI-based emotional empathy technology, and in December, it plans to introduce new features such as emotion-based morning narration, automatically generated meditation and sleep content, and AI self-diagnosis reports.

Dr. Wonhyeok Lee, who is in charge of bio app development at Lysol, said, “Sleepisol Bio is positioned as the world’s first circadian rhythm-based sleep solution, and we plan to expand into an integrated health management service in the future, from personalized diet and exercise coaching to blood pressure and blood sugar management.”


  • See more related articles